While variation in fibrillary morphologies explained variation in TIL counts across individual tumors, these morphologies did not distinguish tumors exhibiting variation in tumor killing nor did they align with presence of other important features of the ECM such as amyloid or mucin. This evidence concerns the gene MUC5AC and neoplasm.